
Richard Novak, PhD
Developing effective novel therapies for rare diseases using existing drugs to unravel and clinically validate complex biological mechanisms.
Richard Novak, PhD
Developing effective novel therapies for rare diseases using existing drugs to unravel and clinically validate complex biological mechanisms.
CLASS OF 2024
COMPANY
LOCATION
Boston, MA
AREA OF FOCUS
Rare disease therapeutics
BIO
Richard Novak, Ph.D. is a bioengineer and entrepreneur dedicated to solving unanswerable questions through technology innovation. He co-founded Unravel Biosciences and serves as its CEO. Prior to Unravel Bio, he was a Lead Engineer at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he managed fast-paced programs in drug discovery, advanced disease models, human Organ Chips, and integrated automation and sensor systems. He has over 15 years of experience in drug discovery system development and applications in the therapeutic space. He is a founder and president of the nonprofit Future Scientist and a founder of the sample collection automation company, Rhinostics Inc.